Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Pharm Source
Pharm Source
Activities:
Media
X
LinkedIn
Trending Articles
Innovation in generics: increased efficiency through peptide API synthesis expertise
Leading Swiss pharmaceutical company Bachem explains the benefits of converging LPPS in the manufacturing of gonadotropin-releasing hormone (GnRH) analogues
COVID-19 still a significant risk for the immunocompromised, study finds
AstraZeneca's INFORM study highlights the persistent danger of COVID-19 for the immunocompromised despite the vaccination scheme
US court lifts modified consent decree on Xellia’s Cleveland facility
The Modified Consent Decree imposed on Xellia's Cleveland facility in 2016 has been vacated, receiving a VAI
Lonza's AI-enabled small molecule development tool launches
The company's AI-enabled Route Scouting Service will optimise synthetic route identification when identifying novel APIs
Autoscribe Informatics’ new Australia office supports business growth
The company's move to West Lakes Adelaide expands its ability to service the Asia Pacific region in digitalising laboratory information
Upcoming event
ASGCT Annual Meeting 2024
7-11 May, 2024 | Meeting | Portland, OR
See all
Related Content
Manufacturing
CPhI 2019 Annual Report: The future of patient-centric CDMOs in the spotlight
Experts Peter Soelkner of Vetter Pharma, Stewart Needleman of Piramal Pharma Solutions, and Adam Bradbury, Industry Analyst at Pharmsource, share views on the challenges ahead
You need to be a subscriber to read this article.
Click here
to find out more.
Media
New stage set for finished dosage form providers
Susan Birks reports on the addition of Finish Dosage Formulation (FDF) to this year’s CPhI Worldwide event
Subscribe now